hVIVO to host capital markets day as it pitches broader clinical development role

hVIVO PLC (AIM:HVO), the human challenge trial specialist, will hold a capital markets day on 11 June in Canary Wharf as it seeks to reposition itself as a full-service early clinical development partner. The event will feature speakers from Boehringer Ingelheim, RA Capital, ILiAD Biotechnologies and Decoy Therapeutics, alongside hVIVO's own leadership team.